Maria Cristofaro, MD
Emergency Medicine · New Britain, CTNPI 1336251495
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Pfizer at 56.6% of the total. Among emergency medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$331
- AstraZeneca$112
- CSL Behring$71
- E.r. Squibb & Sons, L.L.C.$38
- Grifols USA, LLC$17
- Purdue Pharma L.p.$16
What the payments were for
- Food & beverage$584100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 19 | $331 |
| AstraZeneca(2 entities) | 6 | $112 |
| CSL Behring | 3 | $71 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Grifols USA, LLC | 1 | $17 |
| Purdue Pharma L.p. | 1 | $16 |
How this compares
$584 in reported general payments places this provider in the 90th percentile of 700 emergency medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 99 | $286 |
| Cyclobenzaprine Hcl | 67 | $227 |
| Cephalexin | 29 | $177 |
| Doxycycline Hyclate | 23 | $169 |
| Methylprednisolone | 22 | $132 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $94 |
| Ibuprofen | 22 | $93 |
| Amoxicillin | 15 | $74 |
| Meloxicam | 52 | $45 |
| Prednisone | 22 | $42 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in New Britain
- David BuonoNew Britain$2K
- Anthony FaustiniNew Britain$969
- Colin FaithNew Britain$492
- Ronald ClarkNew Britain$452
- James MaternNew Britain$429
- Chi Kong PoonHartford$65K
- Kristine DoyleMiddletown$44K
- Brian BaxtPutnam$36K
- Thomas RobeyNew Haven$20K
- David WilcoxMiddletown$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.